Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform, SQore. Its SQore platform is designed to enable the conversion of intravenous (IV) biologics to subcutaneous (SQ) versions. The company is advancing its primary product programs, CLS-001, a preclinical stage biobetter for Crohn's and Ulcerative Colitis disease, and CLS-002, a preclinical stage biobetter for various oncology indications. Comera Life Sciences Holdings, Inc. was founded in 2014 and is headquartered in Woburn, Massachusetts.
NASDAQ
Unprofitable
EPS improving
Unprofitable
EPS improving
6148
Biotechnology
Relative Strenght
0Volume Buzz
100%Earning Acce
YesDist 52w H.
NaN%